ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,184Medicare Part D Prescriptions Filled, Including Refills

Rank: 151 out of 1269

$405K Total Retail Price of All Prescriptions

Rank: 218 out of 1269

231 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 231 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 231 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,384 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
WARFARIN SODIUM 326 323 1 12
LISINOPRIL 244 220 2 1
AMLODIPINE BESYLATE 234 202 3 2
LEVOTHYROXINE SODIUM 216 201 4 4
METOPROLOL TARTRATE 201 179 5 6
FUROSEMIDE 183 179 6 5
OMEPRAZOLE 165 161 7 8
SIMVASTATIN 160 134 8 3
CITALOPRAM HBR 157 157 9 21
MIRTAZAPINE 144 144 10 24
TRAMADOL HCL 132 127 11 16
RISPERIDONE 117 104 12 43
PRAVASTATIN SODIUM 113 98 13 11
METFORMIN HCL 108 100 14 9
ATORVASTATIN CALCIUM 102 94 15 7
OXYCODONE-ACETAMINOPHEN 98 65 S2 16 44
CRESTOR 94 59 17 25
HYDROCHLOROTHIAZIDE 93 78 18 10
GABAPENTIN 85 40 19 17
DIOVAN 79 76 20 35
JANTOVEN 77 75 21 52
LANTUS 76 76 22 39
POLYETHYLENE GLYCOL 3350 74 59 23 50
ALENDRONATE SODIUM 74 74 23 28
LOSARTAN POTASSIUM 72 64 25 15
POTASSIUM CHLORIDE 72 69 25 26
RANITIDINE HCL 71 71 27 27
QUETIAPINE FUMARATE 71 70 27 53
FENTANYL 67 0 S2 29 105
PANTOPRAZOLE SODIUM 65 60 30 18
ATENOLOL 58 55 31 14
TRAZODONE HCL 55 55 32 36
CARVEDILOL 55 55 32 29
METOPROLOL SUCCINATE 52 48 34 13
FOSINOPRIL SODIUM 50 45 35 319
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.